KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Emergent BioSolutions (EBS) over the last 16 years, with Q3 2025 value amounting to $51.2 million.

  • Emergent BioSolutions' Income towards Parent Company fell 5540.07% to $51.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.9 million, marking a year-over-year increase of 13635.06%. This contributed to the annual value of -$190.6 million for FY2024, which is 7493.75% up from last year.
  • Latest data reveals that Emergent BioSolutions reported Income towards Parent Company of $51.2 million as of Q3 2025, which was down 5540.07% from -$12.0 million recorded in Q2 2025.
  • Emergent BioSolutions' 5-year Income towards Parent Company high stood at $177.9 million for Q4 2021, and its period low was -$283.1 million during Q2 2024.
  • In the last 5 years, Emergent BioSolutions' Income towards Parent Company had a median value of -$31.3 million in 2024 and averaged -$44.1 million.
  • Its Income towards Parent Company has fluctuated over the past 5 years, first soared by 65760.0% in 2021, then crashed by 493243.24% in 2023.
  • Over the past 5 years, Emergent BioSolutions' Income towards Parent Company (Quarter) stood at $177.9 million in 2021, then plummeted by 137.66% to -$67.0 million in 2022, then increased by 26.12% to -$49.5 million in 2023, then surged by 36.77% to -$31.3 million in 2024, then soared by 263.58% to $51.2 million in 2025.
  • Its Income towards Parent Company stands at $51.2 million for Q3 2025, versus -$12.0 million for Q2 2025 and $68.0 million for Q1 2025.